Mirador Therapeutics
Mirador Therapeutics develops precision medicines for immune-mediated inflammatory and fibrotic diseases using an integrated discovery and development platform. The company’s Mirador360 engine combines human genetics, multi-modal data, and analytical tools to identify therapeutic targets, support patient stratification, and inform drug design. Its offerings include research programs and pipeline assets aimed at conditions such as chronic inflammation and tissue fibrosis. Mirador Therapeutics works with scientific and medical stakeholders to advance targeted therapeutic candidates through preclinical and clinical development.
Domain
miradortx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$250.0M
Founded
2023
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Mirador Therapeutics use?+
Mirador Therapeutics uses 14 technologies including Cookiebot, Drupal, Google Analytics.
What industry is Mirador Therapeutics in?+
Mirador Therapeutics operates in the Biotechnology industry.
Where is Mirador Therapeutics based?+
Mirador Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026